Vitrafy Life Sciences Limited (ASX: VFY)
Health Care · Life Sciences Tools & Services · AU
AU$3.11
-12.64% today · +145.8% 1Y
Vitrafy Life Sciences Limited (ASX: VFY) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $165.37M.
Over the last twelve months the share price has gained 145.8%, trading between 1.20 and 4.66.
Tweenvest scores Vitrafy Life Sciences Limited across four factors: quality 38/100, value 54/100. Its strongest factor is value.
VFY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $165.37M
- Revenue (TTM)
- $144.59K
- P/E
- —
- EPS
- -0.25
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- AU$4.66
- 52-week low
- AU$1.20
- Avg volume (3M)
- —
- Shares outstanding
- 76.20M
- Employees
- —
- Next earnings
- —
About Vitrafy Life Sciences Limited
Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems. Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.
- ISIN
- AU0000361297
- Founded
- 2017
- Listed since
- Nov 21, 2024
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
| Tarsons Products LimitedNSEI: TARSONS | $176.45M | Rs320.95 | -2.57% |
| Fine Foods & Pharmaceuticals N.T.M. S.p.A.BIT: FF | $168.81M | €6.78 | +1.19% |
| BICO Group AB (publ)OM: BICO | $167.28M | Skr24.30 | +2.53% |
| BLS Pharmaceuticals LimitedASX: BLS | $163.93M | AU$1.02 | -0.97% |
| Quanterix CorporationNasdaqGM: QTRX | $155.12M | $3.28 | +2.18% |
| Codexis, Inc.NasdaqGS: CDXS | $154.40M | $1.41 | +3.68% |
| FutureChem Co.,LtdKOSDAQ: A220100 | $140.90M | ₩7,040.00 | -2.09% |
Figures last refreshed Oct 11, 2026.